Page last updated: 2024-08-17
thymidine and bi 2536
thymidine has been researched along with bi 2536 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Cerny-Reiterer, S; Ferenc, V; Gleixner, KV; Hadzijusufovic, E; Herrmann, H; Horny, HP; Mirkina, I; Müllauer, L; Peter, B; Pickl, WF; Schuch, K; Valent, P; Willmann, M; Winter, V | 1 |
Other Studies
1 other study(ies) available for thymidine and bi 2536
| Article | Year |
|---|---|
Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536.
Topics: Animals; Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Flow Cytometry; HL-60 Cells; Humans; Immunohistochemistry; K562 Cells; Mast Cells; Mastocytosis, Systemic; Phosphorylation; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Thymidine; Tumor Cells, Cultured; U937 Cells | 2011 |